Literature DB >> 8495169

Effective and acceptable treatment for depression.

J Nakielny.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495169      PMCID: PMC1677542          DOI: 10.1136/bmj.306.6885.1125-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Fluoxetine versus trazodone: efficacy and activating-sedating effects.

Authors:  C M Beasley; B E Dornseif; J A Pultz; J C Bosomworth; M E Sayler
Journal:  J Clin Psychiatry       Date:  1991-07       Impact factor: 4.384

2.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Authors:  F Song; N Freemantle; T A Sheldon; A House; P Watson; A Long; J Mason
Journal:  BMJ       Date:  1993-03-13

Review 3.  Toxicity of antidepressants: comparisons with fluoxetine.

Authors:  J A Henry
Journal:  Int Clin Psychopharmacol       Date:  1992-06       Impact factor: 1.659

4.  Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.

Authors:  R Noguera; R Altuna; E Alvarez; J L Ayuso; L Casais; C Udina
Journal:  J Affect Disord       Date:  1991-07       Impact factor: 4.839

  4 in total
  5 in total

Review 1.  Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Authors:  Anders W Jørgensen; Jørgen Hilden; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-10-06

Review 2.  A systematic review of conflicting meta-analyses in orthopaedic surgery.

Authors:  Patrick Vavken; Ronald Dorotka
Journal:  Clin Orthop Relat Res       Date:  2009-02-28       Impact factor: 4.176

Review 3.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 4.  Paroxetine. A pharmacoeconomic evaluation of its use in depression.

Authors:  M I Wilde; R Whittington
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 5.  Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.

Authors:  Helle Krogh Johansen; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2014-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.